1. Just-Nubling G, Gentschew G, Meissner K, etal Fluconazole prophylaxis 15. Marriott DJ, Jones PD, Hoy JF, Speed BR, Harkness JL. Fluconazole once of recurrent oral candidiasis in HIV-positive patients. Eur J Clin Micro- a week as secondary prophylaxis against oropharyngeal candidiasis in biol Infect Dis 1991; 10:917 0 21. HIV-infected patients: a double-blind placebo-controlled study. Med J
2. Powderly WG. Resistant candidiasis. AIDS Res Hum Retroviruses 1994; Aust 1993; 158:312 0 6. 10:925 0 9. 16. Schuman P, Capps L, Peng G, et al. Weekly Ouconazole for the prevention
3. Stevens DA, Greene SI, Lang OS. Thrush can be prevented in patients of mucosal candidiasis in women with HIV infection: a randomized, with acquired immunodeAEciency syndrome and the acquired immunode- double-blind, placebo-controlled trial. Ann Intern Med 1997; 126: AEciency syndrome 0 related complex: randomized, double-blind, pla- 689 0 96. cebo-controlled study of 100-mg oral Ouconazole daily. Arch Intern 17. Ruhnke M, Eigler A, Tennagen I, Geiseler B, Engelmann E, Trautmann Med 1991; 151:2458 0 64. M. Emergence of Ouconazole-resistant strains of Candida albicans in
4. Chuck SL, Sande MA. Infections with Cryptococcus neoformans in the patients with recurrent oropharyngeal candidosis and human immunodeacquired immunodeAEciency syndrome. N Engl J Med 1989; 321: AEciency virus infection. J Clin Microbiol 1994; 32:2092 0 8. 794 0 9. 18. Barchiesi F, Hollis RJ, McGough DA, Scalise G, Rinaldi MG, Pfaller